- You can view the full Eli Lilly and Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The stocks we thought would be the strongest in 2016 are now losing their footing, Cramer says.
Eli Lilly (LLY) was upgraded to 'buy' from 'neutral' on Tuesday at Goldman Sachs.
Here are Tuesday's top research calls, including upgrades for AutoZone and Eli Lilly, and downgrades for J.M. Smucker and Toll Brothers.